Phase III, Randomized, Double-Blind, Placebo-Controlled, Trial of Linaclotide Administered to Patients With Chronic Constipation
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial of Linaclotide Administered Orally for 12 Weeks in Patients With Chronic Constipation
研究概览
研究类型
注册 (实际的)
阶段
- 第三阶段
联系人和位置
学习地点
-
-
British Columbia
-
Vancouver、British Columbia、加拿大、V67 2K5
- Forest Investigative Site
-
-
Ontario
-
Hamilton、Ontario、加拿大、L8N 4A6
- Forest Investigative Site
-
Newmarket、Ontario、加拿大、L3Y 7V1
- Forest Investigative Site
-
Ottawa、Ontario、加拿大、K2c 3R2
- Forest Investigative Site
-
Sarnia、Ontario、加拿大、N7T 4X3
- Forest Investigative Site 1
-
Sarnia、Ontario、加拿大、N7T 4X3
- Forest Investigative Site 2
-
Sudbury、Ontario、加拿大、P3E 1H5
- Forest Investigative Site
-
Toronto、Ontario、加拿大、MCN 2V7
- Forest Investigative Site
-
-
-
-
Alabama
-
Birmingham、Alabama、美国、35205
- Forest Investigative Site
-
Birmingham、Alabama、美国、35215
- Forest Investigative Site
-
Huntsville、Alabama、美国、35801
- Forest Investigative Site
-
-
Arizona
-
Chandler、Arizona、美国、85225
- Forest Investigative Site
-
Mesa、Arizona、美国、85210
- Forest Investigative Site
-
Peoria、Arizona、美国、85381
- Forest Investigative Site
-
Phoenix、Arizona、美国、85012
- Forest Investigative Site
-
Scottsdale、Arizona、美国、85251
- Forest Investigative Site
-
Tucson、Arizona、美国、85741
- Forest Investigative Site
-
-
California
-
Burbank、California、美国、91505
- Forest Investigative Site
-
Encinitas、California、美国、92024
- Forest Investigative Site
-
Foothill Ranch、California、美国、92610
- Forest Investigative Site
-
Los Angeles、California、美国、90036
- Forest Investigative Site
-
Orange、California、美国、92869
- Forest Investigative Site
-
Westlake Village、California、美国、91361
- Forest Investigative Site
-
-
Colorado
-
Boulder、Colorado、美国、80304
- Forest Investigative Site
-
Colorado Springs、Colorado、美国、80909
- Forest Investigative Site
-
Denver、Colorado、美国、80205
- Forest Investigative Sites
-
Longmont、Colorado、美国、80501
- Forest Investigative Site
-
Wheat Ridge、Colorado、美国、80033
- Forest Investigative Site
-
-
Connecticut
-
Waterbury、Connecticut、美国、06708
- Forest Investigative Site
-
-
Florida
-
Boca Raton、Florida、美国、33486
- Forest Investigative Site
-
Bradenton、Florida、美国、34203
- Forest Investigative Site
-
Brooksville、Florida、美国、34601
- Forest Investigative Site
-
Ft. Myers、Florida、美国、33916
- Forest Investigative Site
-
Jupiter、Florida、美国、33458
- Forest Investigative Site
-
Kissimmee、Florida、美国、34741
- Forest Investigative Site
-
Miami、Florida、美国、33143
- Forest Investigative Site
-
Ocala、Florida、美国、34471
- Forest Investigative Site
-
Orlando、Florida、美国、32806
- Forest Investigative Site
-
Panama City、Florida、美国、32405
- Forest Investigative Site
-
Pembroke Pines、Florida、美国、33024
- Forest Investigative Site
-
St. Petersburg、Florida、美国、33709
- Forest Investigative Site
-
Tampa、Florida、美国、33606
- Forest Investigative Site
-
Trinity、Florida、美国、34655
- Forest Investigative Site
-
Zephyrhills、Florida、美国、33542
- Forest Investigative Site
-
-
Georgia
-
Atlanta、Georgia、美国、30342
- Forest Investigative Site
-
Marietta、Georgia、美国、30060
- Forest Investigative Site
-
Marietta、Georgia、美国、30067
- Forest Investigative Site
-
Stockbridge、Georgia、美国、30281
- Forest Investigative Site
-
Woodstock、Georgia、美国、30189
- Forest Investigative Site
-
-
Idaho
-
Idaho Falls、Idaho、美国、83404
- Forest Investigative Site
-
-
Illinois
-
Rockford、Illinois、美国、61107
- Forest Investigative Site
-
-
Indiana
-
Elkhart、Indiana、美国、46514
- Forest Investigative Site
-
Evansville、Indiana、美国、47714
- Forest Investigative Site
-
Indianapolis、Indiana、美国、46237
- Forest Investigative Site
-
Indianapolis、Indiana、美国、46254
- Forest Investigative Site
-
-
Iowa
-
Iowa City、Iowa、美国、52242
- Forest Investigative Site
-
-
Kansas
-
Arkansas City、Kansas、美国、67005
- Forest Investigative Site
-
Newton、Kansas、美国、67114
- Forest Investigative Site
-
Wichita、Kansas、美国、67205
- Forest Investigative Site
-
Wichita、Kansas、美国、67207
- Forest Investigative Site
-
-
Kentucky
-
Lexington、Kentucky、美国、40509
- Forest Investigative Site
-
Madisonville、Kentucky、美国、42431
- Forest Investigative Site
-
-
Maryland
-
Chevy Chase、Maryland、美国、20815
- Forest Investigative Site
-
Hagerstown、Maryland、美国、21742
- Forest Investigative Site
-
Lutherville、Maryland、美国、21093
- Forest Investigative Site
-
-
Massachusetts
-
Boston、Massachusetts、美国、02135
- Forest Investigative Site
-
-
Minnesota
-
Chaska、Minnesota、美国、55318
- Forest Investigative Site
-
-
Missouri
-
St. Louis、Missouri、美国、63110
- Forest Investigative Site
-
St. Louis、Missouri、美国、63128
- Forest Investigative Site
-
-
New Jersey
-
Vineland、New Jersey、美国、08360
- Forest Investigative Site
-
-
New Mexico
-
Albuquerque、New Mexico、美国、87106
- Forest Investigative Site
-
-
New York
-
Brooklyn、New York、美国、11214
- Forest Investigative Site
-
Great Neck、New York、美国、11021
- Forest Investigative Site
-
Great Neck、New York、美国、11023
- Forest Investigative Site
-
-
North Carolina
-
Fayetteville、North Carolina、美国、28304
- Forest Investigative Site
-
Greensboro、North Carolina、美国、27403
- Forest Investigative Site
-
Hickory、North Carolina、美国、28601
- Forest Investigative Site
-
Raleigh、North Carolina、美国、27612
- Forest Investigative Site
-
Wilmington、North Carolina、美国、28401
- Forest Investigative Site
-
Winston-Salem、North Carolina、美国、27103
- Forest Investigative Site
-
-
North Dakota
-
Bismark、North Dakota、美国、58501
- Forest Investigative Site
-
-
Ohio
-
Akron、Ohio、美国、44302
- Forest Investigative Site
-
Cincinnati、Ohio、美国、45219
- Forest Investigative Site
-
Cleveland、Ohio、美国、44122
- Forest Investigative Site
-
-
Oklahoma
-
Oklahoma City、Oklahoma、美国、73104
- Forest Investigative Site
-
Tulsa、Oklahoma、美国、74135
- Forest Investigative Site
-
-
Pennsylvania
-
Bensalem、Pennsylvania、美国、19020
- Forest Investigative Site
-
Pittsburgh、Pennsylvania、美国、15206
- Forest Investigative Site
-
-
South Carolina
-
Greenville、South Carolina、美国、29615
- Forest Investigative Site
-
Greer、South Carolina、美国、29651
- Forest Investigative Site
-
-
Tennessee
-
Nashville、Tennessee、美国、37205
- Forest Investigative Site
-
-
Texas
-
Austin、Texas、美国、78705
- Forest Investigative Site
-
Dallas、Texas、美国、75234
- Forest Investigative Site
-
Houston、Texas、美国、77090
- Forest Investigative Site
-
Lake Jackson、Texas、美国、77566
- Forest Investigative Site
-
San Antonio、Texas、美国、78229
- Forest Investigative Site
-
San Antonio、Texas、美国、78209
- Forest Investigative Site
-
-
Utah
-
Salt Lake City、Utah、美国、84102
- Forest Investigative Site
-
-
Virginia
-
Charlottesville、Virginia、美国、22911
- Forest Investigative Site
-
Christianburg、Virginia、美国、24073
- Forest Investigative Site
-
Newport News、Virginia、美国、23606
- Forest Investigative Site
-
Norfolk、Virginia、美国、23502
- Forest Investigative Site
-
Norfolk、Virginia、美国、23507
- Forest Investigative Site
-
Richmond、Virginia、美国、23294
- Forest Investigative Site
-
-
Washington
-
Bellevue、Washington、美国、98402
- Forest Investigative Site
-
Lakewood、Washington、美国、98499
- Forest Investigative Site
-
Wenatchee、Washington、美国、98801
- Forest Investigative Site
-
-
Wisconsin
-
Milwaukee、Wisconsin、美国、53209
- Forest Investigative Site
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Patient has completed a colonoscopy according to the AGA criteria, with no clinically significant findings
- Patient has successfully completed protocol procedures (with no clinically significant findings): physical exam, 12-lead ECG, or clinical laboratory tests
- Patient meets protocol criteria for CC: reports < 3 bowel movements per week and reports straining, lumpy or hard stools, and/or sensation of incomplete evacuation during > 25% of BMs
- Patient demonstrates continued chronic constipation through Pretreatment Period
- Patient is compliant with IVRS
Exclusion Criteria:
- Patient has history of loose or watery stools
- Patient has symptoms of or been diagnosed with Irritable Bowel Syndrome (IBS)
- Patient has a structural abnormality of the gastrointestinal (GI) tract or a disease or condition that can affect GI motility
- Patient has any protocol-excluded or clinically significant medical or surgical history that could confound the study assessments
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:四人间
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:1
Linaclotide 290 micrograms
|
在研究期间,每天早上至少在早餐前 30 分钟口服一次
|
|
实验性的:2
Linaclotide 145 micrograms
|
Oral, once daily each morning at least 30 minutes before breakfast for the duration of the study
|
|
安慰剂比较:3
Matching placebo
|
Oral, once daily each morning at least 30 minutes before breakfast for the duration of the study
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Complete Spontaneous Bowel Movement (CSBM) Overall Responder
大体时间:Change from Baseline to Week 12
|
A 12-week CSBM overall responders was defined as a patient who for at least 9 of the 12 weeks of the treatment period had a CSBM weekly frequency rate that was 3 or greater and increased by 1 or more from baseline. A CSBM was defined as a spontaneous bowel movement (SBM) that was associated with a sense of complete evacuation. An SBM was defined as a bowel movement (BM) that occurred in the absence of laxative, enema, or suppository use on either the calendar day of the BM or the calendar day before the BM. |
Change from Baseline to Week 12
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
12-week Complete Spontaneous Bowel Movement (CSBM) Frequency Rate
大体时间:Change from Baseline to Week 12
|
The number of CSBMs per week.
|
Change from Baseline to Week 12
|
|
12-Week Spontaneous Bowel Movement (SBM) Frequency Rate
大体时间:Change from Baseline to Week 12
|
A patient's 12-week spontaneous bowel movement (SBM) frequency rate was the number of SBMs per week calculated over the 12-weeks of the treatment period.
|
Change from Baseline to Week 12
|
|
12-Week Stool Consistency
大体时间:Change from Baseline to Week 12
|
The consistency of each BM was assessed using the 7-point Bristol Stool Form Scale:
|
Change from Baseline to Week 12
|
|
12-Week Severity of Straining
大体时间:Change from Baseline to Week 12
|
Straining is measured on a 5-point scale, where a value of 1 is "not at all" and a value of 5 is "an extreme amount.
|
Change from Baseline to Week 12
|
|
12-Week Abdominal Discomfort
大体时间:Change from Baseline to Week 12
|
Abdominal discomfort is based on a 5-point scale where a value of l is "none" and a value of 5 is "very severe."
|
Change from Baseline to Week 12
|
|
12-Week Bloating
大体时间:Change from Baseline to Week 12
|
Bloating was based on a 5-point scale where a value of l is "none" and a value of 5 is "very severe".
|
Change from Baseline to Week 12
|
|
12-Week Constipation Severity
大体时间:Change from Baseline to Week 12
|
Constipation severity was based on a 5-point ordinal scale where a value of l is "none" and a value of 5 is "very severe".
|
Change from Baseline to Week 12
|
合作者和调查者
调查人员
- 研究主任:Paul F.C. Eng, PhD、Forest Laboratories
出版物和有用的链接
一般刊物
- Chang L, Lembo AJ, Lavins BJ, Shiff SJ, Hao X, Chickering JG, Jia XD, Currie MG, Kurtz CB, Johnston JM. The impact of abdominal pain on global measures in patients with chronic idiopathic constipation, before and after treatment with linaclotide: a pooled analysis of two randomised, double-blind, placebo-controlled, phase 3 trials. Aliment Pharmacol Ther. 2014 Dec;40(11-12):1302-12. doi: 10.1111/apt.12985. Epub 2014 Oct 13.
- Lembo AJ, Schneier HA, Shiff SJ, Kurtz CB, MacDougall JE, Jia XD, Shao JZ, Lavins BJ, Currie MG, Fitch DA, Jeglinski BI, Eng P, Fox SM, Johnston JM. Two randomized trials of linaclotide for chronic constipation. N Engl J Med. 2011 Aug 11;365(6):527-36. doi: 10.1056/NEJMoa1010863.
研究记录日期
研究主要日期
学习开始
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (估计)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.